Curcumin and nano‐curcumin applications in psychiatric disorders

Psychiatric disorders cause long‐lasting disabilities across different age groups. While various medications are available for mental disorders, some patients do not fully benefit from them or experience treatment resistance. The pathogenesis of psychiatric disorders involves multiple mechanisms, in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Phytotherapy research Jg. 38; H. 8; S. 4240 - 4260
Hauptverfasser:	Mohammadzadeh, R., Fathi, M., Pourseif, M. M., Omidi, Y., Farhang, S., Barzegar Jalali, M., Valizadeh, H., Nakhlband, A., Adibkia, K.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Chichester, UK John Wiley & Sons, Ltd 01.08.2024 Wiley Subscription Services, Inc
Schlagworte:	Animals Antidepressants Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use anxiety Anxiety disorders Anxiety Disorders - drug therapy Bipolar disorder Bipolar Disorder - drug therapy Clinical trials Curcumin Curcumin - chemistry Curcumin - pharmacology Curcumin - therapeutic use Depressive Disorder, Major - drug therapy Dosage Effectiveness Humans inflammation Inflammatory response Liposomes - chemistry Mental depression Mental disorders Mental Disorders - drug therapy nanocurcumin Nanoparticles Nanoparticles - chemistry Neuroprotection Pathogenesis phytotherapy psychiatric disorders Schizophrenia Schizophrenia - drug therapy Treatment resistance nanocurcumin curcumin psychiatric disorders
ISSN:	0951-418X, 1099-1573, 1099-1573
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!